Physicochemical principles and clinical results concerning the conservative treatment of kidney stones are discussed. Litholytic agents, developed over the last decades, are able to dissolve a number of kidney stones either directly through a retrograde irrigation of the kidney cavities or indirectly by using suitable drugs which can be administered orally or intravenously. Both ways of administration have their advantages and problems. The relation of chemical, physical, bacteriological, anatomical and metabolic factors to stone formation, as well as to stone dissolution and/or stone prophylaxis (metaphylaxis), is demonstrated. In addition, attention is called to the four physical factors – (1) crystallizing propensity, (2) exceeding the saturation point of the urine, (3) urine pH, and (4) ‘salting out’ effect – and their influence on stone formation. Factors promoting or preventing crystallization are classified in a biological relation. According to this ‘relation, it is theoretically possible by selective elimination of substances promoting crystallization to achieve suitable conditions for dissolving uric acid, phosphate and L-cystine stones and also to inhibit stone formation (prophylaxis/metaphylaxis). The frequency of recurrent calcium oxalate calculi can be reduced by achieving ‘anti-salting out’ conditions in human urine. These ideas were proved experimentally and in a preliminary clinical study with a limited number of kidney-stone patients.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.